PDCD1 and neoplasm: Therefore, in murine ATC, the combination of BRAF inhibitor PLX4720 and anti-PD-1/PD-L1 antibody was found to not only inhibit tumor growth, prolong the survival time of mice, but also reshape the immune system and improve the quality of life 130.